| EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer AM Haslehurst, M Koti, M Dharsee, P Nuin, K Evans, J Geraci, T Childs, ... BMC cancer 12, 1-10, 2012 | 445 | 2012 |
| The immunopathophysiology of endometriosis LK Symons, JE Miller, VR Kay, RM Marks, K Liblik, M Koti, C Tayade Trends in molecular medicine 24 (9), 748-762, 2018 | 371 | 2018 |
| Mechanisms of hypoxia-mediated immune escape in cancer IB Barsoum, M Koti, DR Siemens, CH Graham Cancer research 74 (24), 7185-7190, 2014 | 194 | 2014 |
| The tumor immune contexture of prostate cancer N Vitkin, S Nersesian, DR Siemens, M Koti Frontiers in immunology 10, 603, 2019 | 182 | 2019 |
| Implications of immune dysfunction on endometriosis associated infertility JE Miller, SH Ahn, SP Monsanto, K Khalaj, M Koti, C Tayade Oncotarget 8 (4), 7138, 2017 | 180 | 2017 |
| Activation of the PD-1/PD-L1 immune checkpoint confers tumor cell chemoresistance associated with increased metastasis M Black, IB Barsoum, P Truesdell, T Cotechini, SK Macdonald-Goodfellow, ... Oncotarget 7 (9), 10557, 2016 | 177 | 2016 |
| Immune-inflammation gene signatures in endometriosis patients SH Ahn, K Khalaj, SL Young, BA Lessey, M Koti, C Tayade Fertility and sterility 106 (6), 1420-1431. e7, 2016 | 173 | 2016 |
| Extracellular vesicle mediated intercellular communication at the porcine maternal-fetal interface: A new paradigm for conceptus-endometrial cross-talk M Bidarimath, K Khalaj, RT Kridli, FWK Kan, M Koti, C Tayade Scientific reports 7 (1), 40476, 2017 | 157 | 2017 |
| STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancer A Ghaffari, N Peterson, K Khalaj, N Vitkin, A Robinson, JA Francis, M Koti British journal of cancer 119 (4), 440-449, 2018 | 135 | 2018 |
| Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous … M Koti, RJ Gooding, P Nuin, A Haslehurst, C Crane, J Weberpals, ... BMC cancer 13, 1-11, 2013 | 123 | 2013 |
| Emerging role of PTEN loss in evasion of the immune response to tumours T Vidotto, CM Melo, E Castelli, M Koti, RB Dos Reis, JA Squire British journal of cancer 122 (12), 1732-1743, 2020 | 114 | 2020 |
| A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer M Koti, A Siu, I Clément, M Bidarimath, G Turashvili, A Edwards, K Rahimi, ... British journal of cancer 112 (7), 1215-1222, 2015 | 89 | 2015 |
| L-Arginine stimulates immune response in chickens immunized with intermediate plus strain of infectious bursal disease vaccine C Tayade, TN Jaiswal, SC Mishra, M Koti Vaccine 24 (5), 552-560, 2006 | 78 | 2006 |
| IL-17A modulates peritoneal macrophage recruitment and M2 polarization in endometriosis JE Miller, SH Ahn, RM Marks, SP Monsanto, AT Fazleabas, M Koti, ... Frontiers in Immunology 11, 108, 2020 | 74 | 2020 |
| PTEN‐deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells T Vidotto, FP Saggioro, T Jamaspishvili, DL Chesca, ... The Prostate 79 (9), 969-979, 2019 | 74 | 2019 |
| DNA damage repair gene mutations and their association with tumor immune regulatory gene expression in muscle invasive bladder cancer subtypes T Vidotto, S Nersesian, C Graham, DR Siemens, M Koti Journal for immunotherapy of cancer 7, 1-12, 2019 | 73 | 2019 |
| Interleukin-33 modulates inflammation in endometriosis JE Miller, SP Monsanto, SH Ahn, K Khalaj, AT Fazleabas, SL Young, ... Scientific reports 7 (1), 17903, 2017 | 73 | 2017 |
| Extracellular vesicles from endometriosis patients are characterized by a unique miRNA-lncRNA signature K Khalaj, JE Miller, H Lingegowda, AT Fazleabas, SL Young, BA Lessey, ... JCI insight 4 (18), 2019 | 67 | 2019 |
| Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma JW Martin, S Chilton-MacNeill, M Koti, AJ Van Wijnen, JA Squire, ... PloS one 9 (5), e95843, 2014 | 63 | 2014 |
| Targeting genetic and epigenetic alterations in the treatment of serous ovarian cancer JI Weberpals, M Koti, JA Squire Cancer genetics 204 (10), 525-535, 2011 | 61 | 2011 |
